MK-8931-017 Study – Sponsored by Merck

Completed Study

Ophthalmic exams, Iris and Fundus photography and SD-OCT for Georgetown neurologists who participated in an Alzheimer’s disease clinical trial for the drug MK-8931.

Return to Sub-studies

Connect

Loading ...

Ophthalmologist Website Design | Accessibility Policy
Washington DC MK-8931-017 Study | Alzheimer’s Disease Trial in Maryland | Virginia MK-8931-017 Study